185 related articles for article (PubMed ID: 3498034)
1. Prevalence of anti-SSA (Ro) antibodies in a Mexican population of patients with various systemic rheumatic diseases.
García-de la Torre I; Sánchez-Guerrero A; Salmón-de la Torre G; Hernández-Vázquez L
J Rheumatol; 1987 Jun; 14(3):479-81. PubMed ID: 3498034
[TBL] [Abstract][Full Text] [Related]
2. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
3. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of the anti-Ro(SSA) response in rheumatic diseases.
López-Longo FJ; Rodríguez-Mahou M; Escalona M; Pérez T; Monteagudo I; Sánchez-Atrio A; Grau R; González C; Moreno AC; Carreño L
J Rheumatol; 1994 Aug; 21(8):1450-6. PubMed ID: 7983645
[TBL] [Abstract][Full Text] [Related]
5. Antibody to extractable nuclear antigen in the rheumatic diseases.
McCain GA; Bell DA; Chodirker WB; Komar RR
J Rheumatol; 1978; 5(4):399-406. PubMed ID: 310883
[TBL] [Abstract][Full Text] [Related]
6. Spectrum and clinical significance of autoantibodies against transfer RNA.
Ohosone Y; Ishida M; Takahashi Y; Matsumura M; Hirakata M; Kawahara Y; Nishikawa T; Mimori T
Arthritis Rheum; 1998 Sep; 41(9):1625-31. PubMed ID: 9751095
[TBL] [Abstract][Full Text] [Related]
7. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
8. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
9. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
10. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
[TBL] [Abstract][Full Text] [Related]
11. Lupus pneumonitis and anti-SSA(Ro) antibodies.
Boulware DW; Hedgpeth MT
J Rheumatol; 1989 Apr; 16(4):479-81. PubMed ID: 2664170
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases.
Uesugi H; Ozaki S; Sobajima J; Osakada F; Shirakawa H; Yoshida M; Nakao K
J Rheumatol; 1998 Apr; 25(4):703-9. PubMed ID: 9558172
[TBL] [Abstract][Full Text] [Related]
13. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
Meyer O
Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
[TBL] [Abstract][Full Text] [Related]
14. Profiles of antibodies to histones, DNA and IgG in patients with systemic rheumatic diseases determined by ELISA.
Gripenberg M; Helve T; Kurki P
J Rheumatol; 1985 Oct; 12(5):934-9. PubMed ID: 3878880
[TBL] [Abstract][Full Text] [Related]
15. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura.
Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
Thromb Haemost; 1994 Feb; 71(2):184-7. PubMed ID: 8191396
[TBL] [Abstract][Full Text] [Related]
16. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.
Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM
J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
19. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
20. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
